Sébastien Iva, new Chair of Fab’entech
Sébastien Iva is the new Chief Executive Officer of Fab’entech, a Lyon-based biotech created in 2009 and specialised in the development and production of polyclonal antibodies intended for the treatment of emerging infectious diseases and the development of biodefense solutions. His mission is to ensure its development and transformation, with the stated objective of becoming a key player in the field of polyclonal antibodies. He took over from Bertrand Lépine, founder of Fab’entech, who now becomes a member of the Supervisory Council.
